Archives of Gerontology and Geriatrics
Volume 51, Issue 2 , Pages 129-134 , September 2010

Acute medical management of the non-ST-segment elevation acute coronary syndromes (NSTE-ACS) in older patients

Received 16 April 2009 ,Revised 7 September 2009 ,Accepted 10 September 2009.

References 

  1. Alexander KP, Roe MT, Chen AY, Lytle BL, Pollack , Foody JM, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J. Am. Coll. Cardiol. 2005;46:1479–1487
  2. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, et al. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2549–2569
  3. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br. Med. J. 2002;324:71–86
  4. Antman EM. Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention?. Nat. Clin. Pract. Cardiovasc. Med. 2008;5:184–185
  5. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. J. Am. Med. Assoc. 2000;284:835–842
  6. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am. Heart J. 2005;149:67–73
  7. Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann. Intern. Med. 2004;141:186–195
  8. Bassand J-P, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 2007;28:1598–1660
  9. Becker RC, Moliterno DJ, Jennings LK, Pieper KS, Pei J, Niederman A, et al. Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. Lancet. 2009;373:919–928
  10. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. J. Am. Med. Assoc. 2006;295:180–189
  11. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101:2557–2567
  12. Budaj A, Yusuf S, Mehta SR, Fox KA, Tognoni G, Zhao F, et al. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation. 2002;106:1622–1626
  13. Burkhardt H, Hahn T, Gretz N, Gladisch R. Bedside estimation of the glomerular filtration rate in hospitalized elderly patients. Nephron Clin. Pract. 2005;101:c1–8
  14. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339
  15. Company, T.M., 2008. Angiomax(R) reduced cardiac mortality by 43 percent and improved overall survival by 31 percent at one-year in HORIZONS-AMI Trial. News Release. Available at: www.themedicinescompany.com (accessed: 26 March 2009).
  16. Despotovic N, Erceg P, Nikolic-Despotovic M, Milosevic DP, Davidovic M. Bleeding during enoxaparin treatment more common with age over 75 years and severe renal insufficiency. Drugs Aging. 2007;24:777–779
  17. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. J. Am. Med. Assoc. 2004;291:2727–2733
  18. eMC, 2009. Efient 5mg & 10mg film coated tablets. Summary of product characteristics. Available from: http://emc.medicines.org.uk/medicine/21504/SPC/Efient+5mg+%26+10mg+film+coated+tablets/ (accessed: 27 March 2009).
  19. EMEA, 2009. European Public Assessment Report for Effient. Available from: http://www.emea.europa.eu/humandocs/PDFs/EPAR/Efient/H-984-en6.pdf (accessed: 27 March 2009).
  20. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. J. Am. Med. Assoc. 2004;292:45–54
  21. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br. Med. J. 2006;333:1091
  22. Halon DA, Adawi S, Dobrecky-Mery I, Lewis BS. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. J. Am. Coll. Cardiol. 2004;43:346–352
  23. Januzzi , Buros J, Cannon CP. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial. Clin. Cardiol. 2005;28:238–242
  24. Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, et al. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur. J. Cardiovasc. Prev. Rehabil. 2007;14:312–318
  25. Lagerqvist B, Diderholm E, Lindahl B, Husted S, Kontny F, Stahle E, et al. FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart. 2005;91:1047–1052
  26. Liistro F, Angioli P, Falsini G, Ducci K, Baldassarre S, Burali A, et al. Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome. Heart. 2005;91:1284–1288
  27. Mehta SR, Granger CB, Eikelboom JW, Bassand JP, Wallentin L, Faxon DP, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J. Am. Coll. Cardiol. 2007;50:1742–1751
  28. Moscucci M, Fox KA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur. Heart J. 2003;24:1815–1823
  29. Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation. 2003;108:1682–1687
  30. Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. J. Am. Med. Assoc. 2004;292:89–96
  31. Rich MW. Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly. Am. J. Geriatr. Cardiol. 2006;15:7–11quiz 12
  32. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2007;28:88–136
  33. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042–2049
  34. Schoenenberger AW, Radovanovic D, Stauffer JC, Windecker S, Urban P, Eberli FR, et al. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study. J. Am. Geriatr. Soc. 2008;56:510–516
  35. Siguret V, Pautas E, Gouin-Thibault I. Vitamin K antagonist use in the elderly: special considerations. Future Cardiol. 2007;3:9
  36. Skolnick AH, Alexander KP, Chen AY, Roe MT, Pollack CV, Ohman EM, et al. Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. J. Am. Coll. Cardiol. 2007;49:1790–1797
  37. Steg PG, Bhatt DL, Wilson PW, D’Agostino R, Ohman EM, Rother J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. J. Am. Med. Assoc. 2007;297:1197–1206
  38. White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, et al. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategy trial). J. Am. Coll. Cardiol. 2008;52:807–814
  39. Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am. Heart J. 2006;152:627–635
  40. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2007;357:2001–2015
  41. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 2001;345:494–502

PII: S0167-4943(09)00239-8

doi: 10.1016/j.archger.2009.09.039

Archives of Gerontology and Geriatrics
Volume 51, Issue 2 , Pages 129-134 , September 2010

Article Tools